(Total Views: 153)
Posted On: 12/06/2023 8:02:17 AM
Post# of 19
ARTIVION: GROWING AGGRESSIVELY IN CARDIAC HEALTH MARKET
$AORT
Excited to share an article about Artivion Inc. (NYSE: AORT), a leading company that manufactures, processes, and distributes medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease.
The Company operates in several countries and has an addressable market of over $5.3 billion. Additionally, it has over $1 billion market opportunity in active R&D projects. For FY23, Artivion expects its constant currency revenue growth to be between 8.0% and 12.0% compared to FY22. Beyond 2025, the Company expects revenue CAGR of more than 15%, making it worth watching out for.
Read on to know more:
https://www.aviseanalytics.com/artivion-growi...th-market/
$AORT
Excited to share an article about Artivion Inc. (NYSE: AORT), a leading company that manufactures, processes, and distributes medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease.
The Company operates in several countries and has an addressable market of over $5.3 billion. Additionally, it has over $1 billion market opportunity in active R&D projects. For FY23, Artivion expects its constant currency revenue growth to be between 8.0% and 12.0% compared to FY22. Beyond 2025, the Company expects revenue CAGR of more than 15%, making it worth watching out for.
Read on to know more:
https://www.aviseanalytics.com/artivion-growi...th-market/
(0)
(0)
